Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Antiproliferative and proapoptotic activities of ferulic acid in breast and liver cancer cell lines

Mohammed ElKhazendar1, Juhaina Chalak1, Waseem El-Huneidi2, Arya Vinod3, Wael M Abdel-Rahman4, Eman Abu-Gharbieh5

1College of Medicine; 2Department of Basic Medical Sciences, College of Medicine; 3Sharjah Institute for Medical Research; 4Department of Medical Laboratory Sciences, College of Health Sciences, and Sharjah Institute for Medical Research; 5Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.

For correspondence:-  Eman Abu-Gharbieh   Email: eabugharbieh@sharjah.ac.ae   Tel:+97165057289

Accepted: 22 November 2019        Published: 31 December 2019

Citation: ElKhazendar M, Chalak J, El-Huneidi W, Vinod A, Abdel-Rahman WM, Abu-Gharbieh E. Antiproliferative and proapoptotic activities of ferulic acid in breast and liver cancer cell lines. Trop J Pharm Res 2019; 18(12):2571-2576 doi: 10.4314/tjpr.v18i12.16

© 2019 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To explore the potential anticancer activities of ferulic acid (4-hydroxy-3-methoxycinnamic acid, FA) on two different human cancers cell lines, viz, breast (MCF-7) and hepatocellular (HepG2).
Methods: MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cytotoxicity, Annexin V staining, enzyme-linked immunosorbent assay (ELISA), as well as caspase-8 and -9  activation assays were used to evaluate the proapoptotic and antiproliferative potentials of ferulic acid (FA) on MCF-7 and HepG2 cell lines.
Results: Ferulic acid exerted cytotoxic effects on MCF-7 and HepG2 cell lines with half-maximal inhibitory concentration (IC50) of 75.4 and 81.38 μg/mL, respectively, at 48 h. Annexin V staining revealed evidence of apoptosis. Caspase-8 and-9 levels were elevated in both cell lines after incubation with ferulic acid.
Conclusion: The findings of this study suggest that ferulic acid has promising therapeutic potentials for the treatment of breast and liver cancers by inducing apoptosis via activation of caspase-8 and -9 pathways.

Keywords: Ferulic acid, Apoptosis, Antiproliferative activity, Breast cancer, Caspase, Liver cancer

Impact Factor
Thompson Reuters (ISI): 0.6 (2023)
H-5 index (Google Scholar): 49 (2023)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal:

Archives

2024; 23: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10
2023; 22: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2022; 21: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2021; 20: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2020; 19: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2019; 18: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2018; 17: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2017; 16: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2016; 15: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2015; 14: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2014; 13: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2013; 12: 
1,   2,   3,   4,   5,   6
2012; 11: 
1,   2,   3,   4,   5,   6
2011; 10: 
1,   2,   3,   4,   5,   6
2010; 9: 
1,   2,   3,   4,   5,   6
2009; 8: 
1,   2,   3,   4,   5,   6
2008; 7: 
1,   2,   3,   4
2007; 6: 
1,   2,   3,   4
2006; 5: 
1,   2
2005; 4: 
1,   2
2004; 3: 
1
2003; 2: 
1,   2
2002; 1: 
1,   2

News Updates